Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
269 JPY | +4.26% | +2.67% | +2.28% |
Apr. 19 | Earnings Flash (SNT) SENSTAR TECHNOLOGIES CORPORATION Posts Q4 Revenue $8.9M | MT |
Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+2.28% | 60.39M | |
+0.93% | 26.12B | |
+18.55% | 21.07B | |
-7.41% | 11.96B | |
+24.91% | 11.32B | |
+10.61% | 10.83B | |
+10.96% | 10.16B | |
+1.48% | 8.46B | |
+4.07% | 7.16B | |
+23.57% | 6.91B |
- Stock Market
- Equities
- 6319 Stock
- News SNT Corporation
- Syntara to Begin Phase Two Study for SNT-5505 Combination Therapy Later in 2024 After Government Grant